Y-Intercept (HK)’s Veracyte VCYT Stock Holding History

Y-Intercept (HK)’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32,024	Closed	-$1.03M	–	2195
2026 Q1	$1.03M	Buy	+32,024	New	+$1.19M	0.02%	1018
2025 Q3	–	Sell	-40,501	Closed	-$1.09M	–	2079
2025 Q2	$1.09M	Sell	40,501 -5,276	-12%	-$153K	0.03%	891
2025 Q1	$1.36M	Buy	45,777 +24,416	+114%	+$931K	0.09%	298
2024 Q4	$846K	Buy	+21,361	New	+$809K	0.06%	495
2024 Q1	–	Sell	-20,207	Closed	-$556K	–	1785
2023 Q4	$556K	Sell	20,207 -8,979	-31%	-$217K	0.05%	546
2023 Q3	$652K	Buy	29,186 +12,322	+73%	+$317K	0.06%	464
2023 Q2	$430K	Sell	16,864 -3,596	-18%	-$87.2K	0.05%	617
2023 Q1	$456K	Sell	20,460 -16,261	-44%	-$393K	0.05%	582
2022 Q4	$871K	Buy	+36,721	New	+$853K	0.13%	243
2021 Q2	–	Sell	-5,526	Closed	-$273K	–	920
2021 Q1	$273K	Buy	5,526 +943	+21%	+$54.3K	0.07%	444
2020 Q4	$234K	Buy	+4,583	New	+$212K	0.1%	403

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Y-Intercept (HK)'s VCYT Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 32,024 shares — an estimated $1.03M sold.

Y-Intercept (HK) first reported a position in VCYT in Q4 2020 and held it in 11 quarters. The position peaked at $1.36M in Q1 2025. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Y-Intercept (HK) reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 32,024 Veracyte shares in Q2 2026, an estimated $1.03M.
Y-Intercept (HK) first reported a position in Veracyte in Q4 2020 and held it in 11 quarters.
Y-Intercept (HK)'s Veracyte position peaked at $1.36M in Q1 2025.
371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.